These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12925190)

  • 21. Accumulated p53 protein and UVA protection level of sunscreens.
    Seité S; Moyal D; Verdier MP; Hourseau C; Fourtanier A
    Photodermatol Photoimmunol Photomed; 2000 Feb; 16(1):3-9. PubMed ID: 10721857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sunscreen remanence on the skin: a noninvasive real time in vivo spectral analysis assessing the quenching of specular ultraviolet A light reflectance.
    Piérard GE; Khazaka D; Khazaka G
    J Cosmet Dermatol; 2016 Mar; 15(1):3-9. PubMed ID: 26260120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of UVA protection factors using the persistent pigment darkening (PPD) as the end point. (Part 1). Calibration of the method.
    Moyal D; Chardon A; Kollias N
    Photodermatol Photoimmunol Photomed; 2000 Dec; 16(6):245-9. PubMed ID: 11132126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photoprotective efficacy and photostability of fifteen sunscreen products having the same label SPF subjected to natural sunlight.
    Hojerová J; Medovcíková A; Mikula M
    Int J Pharm; 2011 Apr; 408(1-2):27-38. PubMed ID: 21277959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of ultraviolet-induced skin pigmentation.
    Moyal D
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):243-7. PubMed ID: 15379874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy.
    Gasparro FP
    Environ Health Perspect; 2000 Mar; 108 Suppl 1(Suppl 1):71-8. PubMed ID: 10698724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurements of the protective effect of topically applied sunscreens using in vitro three-dimensional dermal and skin equivalents.
    Augustin C; Collombel C; Damour O
    Photochem Photobiol; 1997 Dec; 66(6):853-9. PubMed ID: 9421971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the UVA protection of sunscreens.
    Roelandts R; Sohrabvand N; Garmyn M
    J Am Acad Dermatol; 1989 Jul; 21(1):56-62. PubMed ID: 2745771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sunscreens containing the broad-spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results.
    Fourtanier A; Moyal D; Seité S
    Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):164-74. PubMed ID: 18717957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the multispectral UV polarization reflectance imaging system (MUPRIS) for in situ monitoring of the UV protection efficacy of sunscreen on human skin.
    Nishino K; Haryu Y; Kinoshita A; Nakauchi S
    Skin Res Technol; 2019 Sep; 25(5):639-652. PubMed ID: 30888092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring sunscreen protection against solar-simulated radiation-induced structural radical damage to skin using ESR/spin trapping: development of an ex vivo test method.
    Haywood R; Volkov A; Andrady C; Sayer R
    Free Radic Res; 2012 Mar; 46(3):265-75. PubMed ID: 22236285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimum erythema dose determination in individuals of skin type V and VI with diffuse reflectance spectroscopy.
    Kollias N; Baqer A; Sadiq I
    Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):249-54. PubMed ID: 7727281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sunscreen's labeled sun protection factor may overestimate protection at temperate latitudes: a human in vivo study.
    Young AR; Boles J; Herzog B; Osterwalder U; Baschong W
    J Invest Dermatol; 2010 Oct; 130(10):2457-62. PubMed ID: 20535128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of sunscreen efficacy over time and re-application using hybrid diffuse reflectance spectroscopy.
    Ruvolo E; Aeschliman L; Cole C
    Photodermatol Photoimmunol Photomed; 2020 May; 36(3):192-199. PubMed ID: 32027038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the UVA protection of commercially available sunscreens.
    Leenutaphong V
    J Med Assoc Thai; 1992 Nov; 75(11):619-24. PubMed ID: 1307384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the protection of sunscreen products against long wavelength ultraviolet A1 and visible light-induced biological effects.
    Ezekwe N; Pourang A; Lyons AB; Narla S; Atyam A; Zia S; Friedman BJ; Hamzavi IH; Lim HW; Kohli I
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12937. PubMed ID: 38069506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Product application technique alters the sun protection factor.
    Sayre RM; Powell J; Rheins LA
    Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):222-4. PubMed ID: 1822686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immediate pigment darkening and persistent pigment darkening as means of measuring the ultraviolet A protection factor in vivo: a comparative study.
    Hwang YJ; Park HJ; Hahn HJ; Kim JY; Ko JH; Lee YW; Choe YB; Ahn KJ
    Br J Dermatol; 2011 Jun; 164(6):1356-61. PubMed ID: 21250967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative behavior between sunscreens based on free or encapsulated UV filters in term of skin penetration, retention and photo-stability.
    Cozzi AC; Perugini P; Gourion-Arsiquaud S
    Eur J Pharm Sci; 2018 Aug; 121():309-318. PubMed ID: 29874551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultraviolet A sunscreen evaluations in normal subjects.
    Stanfield JW; Feldt PA; Csortan ES; Krochmal L
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):744-8. PubMed ID: 2715428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.